Abstract
The aminergic family of G protein-coupled receptors (GPCRs) plays an important role in various diseases and represents a major drug discovery target class. Structure determination of all major aminergic subfamilies has enabled structure-based ligand design for these receptors. Site-directed mutagenesis data provides an invaluable complementary source of information for elucidating the structural determinants of binding of different ligand chemotypes. The current study provides a comparative analysis of 6692 mutation data points on 34 aminergic GPCR subtypes, covering the chemical space of 540 unique ligands from mutagenesis experiments and information from experimentally determined structures of 52 distinct aminergic receptor-ligand complexes. The integrated analysis enables detailed investigation of structural receptor-ligand interactions and assessment of the transferability of combined binding mode and mutation data across ligand chemotypes and receptor subtypes. An overview is provided of the possibilities and limitations of using mutation data to guide the design of novel aminergic receptor ligands.
| Original language | English |
|---|---|
| Number of pages | 56 |
| Journal | Journal of Medicinal Chemistry |
| DOIs | |
| Publication status | Published - 17 Oct 2018 |
Fingerprint
Cite this
}
Aminergic GPCR-Ligand Interactions : A Chemical and Structural Map of Receptor Mutation Data. / Vass, Márton; Podlewska, Sabina; De Esch, Iwan J.P.; Bojarski, Andrzej J.; Leurs, Rob; Kooistra, Albert J.; De Graaf, Chris.
In: Journal of Medicinal Chemistry, 17.10.2018.Research output: Contribution to Journal › Article › Academic › peer-review
TY - JOUR
T1 - Aminergic GPCR-Ligand Interactions
T2 - A Chemical and Structural Map of Receptor Mutation Data
AU - Vass, Márton
AU - Podlewska, Sabina
AU - De Esch, Iwan J.P.
AU - Bojarski, Andrzej J.
AU - Leurs, Rob
AU - Kooistra, Albert J.
AU - De Graaf, Chris
PY - 2018/10/17
Y1 - 2018/10/17
N2 - The aminergic family of G protein-coupled receptors (GPCRs) plays an important role in various diseases and represents a major drug discovery target class. Structure determination of all major aminergic subfamilies has enabled structure-based ligand design for these receptors. Site-directed mutagenesis data provides an invaluable complementary source of information for elucidating the structural determinants of binding of different ligand chemotypes. The current study provides a comparative analysis of 6692 mutation data points on 34 aminergic GPCR subtypes, covering the chemical space of 540 unique ligands from mutagenesis experiments and information from experimentally determined structures of 52 distinct aminergic receptor-ligand complexes. The integrated analysis enables detailed investigation of structural receptor-ligand interactions and assessment of the transferability of combined binding mode and mutation data across ligand chemotypes and receptor subtypes. An overview is provided of the possibilities and limitations of using mutation data to guide the design of novel aminergic receptor ligands.
AB - The aminergic family of G protein-coupled receptors (GPCRs) plays an important role in various diseases and represents a major drug discovery target class. Structure determination of all major aminergic subfamilies has enabled structure-based ligand design for these receptors. Site-directed mutagenesis data provides an invaluable complementary source of information for elucidating the structural determinants of binding of different ligand chemotypes. The current study provides a comparative analysis of 6692 mutation data points on 34 aminergic GPCR subtypes, covering the chemical space of 540 unique ligands from mutagenesis experiments and information from experimentally determined structures of 52 distinct aminergic receptor-ligand complexes. The integrated analysis enables detailed investigation of structural receptor-ligand interactions and assessment of the transferability of combined binding mode and mutation data across ligand chemotypes and receptor subtypes. An overview is provided of the possibilities and limitations of using mutation data to guide the design of novel aminergic receptor ligands.
UR - http://www.scopus.com/inward/record.url?scp=85058134004&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058134004&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.8b00836
DO - 10.1021/acs.jmedchem.8b00836
M3 - Article
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
SN - 0022-2623
ER -